
Astec Lifesciences Ltd is Rated Strong Sell
2026-03-09 10:10:18Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 September 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read full news article
Astec Lifesciences Ltd is Rated Strong Sell
2026-03-08 10:10:26Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Astec Lifesciences Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-03-06 08:01:20Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s technical indicators reveal a mixed picture that investors should carefully analyse amid ongoing market volatility.
Read full news article
Astec Lifesciences Ltd Technical Momentum Shifts Amid Bearish Signals
2026-03-05 08:02:11Astec Lifesciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest intraday price gain of 1.01%, the broader technical landscape suggests caution for investors as bearish signals intensify across multiple timeframes.
Read full news article
Astec Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-03-04 08:03:22Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a modest day gain of 0.50% to close at ₹627.10, the stock’s technical parameters reveal a transition from a bearish to a mildly bearish trend, underscoring cautious optimism amid persistent headwinds.
Read full news article
Astec Lifesciences Ltd is Rated Strong Sell
2026-02-25 10:10:25Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 25 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical standing.
Read full news article
Astec Lifesciences Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-02-24 08:03:20Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, is currently exhibiting a pronounced shift towards bearish momentum as multiple technical indicators signal a deteriorating trend. With a recent downgrade to a Strong Sell rating and a Mojo Score of 17.0, the stock’s technical landscape suggests caution for investors amid weakening price action and subdued market sentiment.
Read full news article
Astec Lifesciences Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-02-23 08:01:28Astec Lifesciences Ltd, a player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s price action and technical parameters warrant a detailed analysis for investors navigating this challenging environment.
Read full news article
Astec Lifesciences Ltd is Rated Strong Sell
2026-02-13 10:10:28Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 13 February 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
24-Feb-2026 | Source : BSEPlease find enclosed Intimation.
Reply On Significant Increase In The Volume Of Security
06-Feb-2026 | Source : BSEPlease see the enclosed reply on significant increase in the volume of security.
Clarification sought from Astec Lifesciences Ltd
06-Feb-2026 | Source : BSEThe Exchange has sought clarification from Astec Lifesciences Ltd on February 06 2026 with reference to Movement in Volume.
The reply is awaited.
Corporate Actions
No Upcoming Board Meetings
Astec Lifesciences Ltd has declared 15% dividend, ex-date: 21 Jul 23
No Splits history available
No Bonus history available
Astec Lifesciences Ltd has announced 1:7 rights issue, ex-date: 04 Jul 25






